A randomised study comparing standard dose carboplatin with chlorambucil and carboplatin in advanced ovarian cancer.

A total of 161 previously untreated patients with FIGO stage III or IV epithelial ovarian cancer were randomised after surgery to receive six courses of either carboplatin 400 mg m-2 alone (Arm A) or carboplatin 300 mg m-2 with chlorambucil 10 mg day-1 for 7 days (Arm B). The median progression free...

Descripción completa

Detalles Bibliográficos
Autores principales: Rankin, E. M., Mill, L., Kaye, S. B., Atkinson, R., Cassidy, L., Cordiner, J., Cruickshank, D., Davis, J., Duncan, I. D., Fullerton, W.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1992
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977737/
https://www.ncbi.nlm.nih.gov/pubmed/1739629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977737/
https://www.ncbi.nlm.nih.gov/pubmed/1739629

Ejemplares similares